Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Cited by (1,053)

Items 801–900 of 1,053

1. Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine?
   David de Gonzalo‐Calvo, Àngela Vea, Christian Bär, Jan Fiedler, Liam S. Couch, Carlos Brotons, Vicenta Llorente‐Cortés, Thomas Thum · 2018 · European Heart Journal
2. Most important advances in preventive cardiology during this past decade: Viewpoint from the American Society for Preventive Cardiology
   Nathan D. Wong, Peter Paul Toth, Ezra A. Amsterdam · 2019 · Trends in Cardiovascular Medicine
3. Potential Benefits and Risks Associated with the Use of Statins
   Nisha Khatiwada, Zhongkui Hong · 2024 · Pharmaceutics
4. Depressive Symptoms, Race, and Circulating C-Reactive Protein: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
   Denise Janicki Deverts, Sheldon Cohen, Vicki G. DiLillo, Cora Elizabeth Lewis, Catarina I. Kiefe, Mary A. Whooley, Karen A. Matthews · 2010 · Psychosomatic Medicine
5. Safety of statins: an update
   Miao Hu, Bernard M.Y. Cheung, Brian Tomlinson · 2012 · Therapeutic Advances in Drug Safety
6. Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome
   Guglielmo Gallone, Luca Baldetti, Matteo Pagnesi, Azeem Latib, Antonio Colombo, Peter Libby, Francesco Giannini · 2018 · Journal of the American College of Cardiology
7. <i>N</i>-of-1 (Single-Patient) Trials for Statin-Related Myalgia
   Joy, Tisha R., Monjed, Alaa, Zou, Guang Yong, Hegele, Robert A., McDonald, Charlotte G., Mahon, Jeffrey L. · 2014 · Annals of Internal Medicine
8. Persistence with Statins and Onset of Rheumatoid Arthritis: A Population-Based Cohort Study
   Gabriel Chodick, Howard Amital, Yoav Shalem, Ehud S. Kokia, Anthony David Heymann, Avi Porath, Varda Shalev · 2010 · PLoS Medicine
9. Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation
   David A. Zidar, Steven M. Juchnowski, Brian Ferrari, Brian M. Clagett, Heather A. Pilch-Cooper, Shawn M. Rose, Benigno A. Rodriguez, Grace A. McComsey, Scott F. Sieg, Nehal N. Mehta et al. · 2015 · JAIDS Journal of Acquired Immune Deficiency Syndromes
10. Statin intolerance because of myalgia, myositis, myopathy, or myonecrosis can in most cases be safely resolved by vitamin d supplementation
    Charles J. Glueck, Ramesh Pandit, Ashwin Kumar, Ping Wang, Maksim Khayznikov, Kallish Hemachrandra · 2015 · North American Journal of Medical Sciences
11. Inflammatory markers in ST-elevation acute myocardial infarction
    Ignacio Miguel Seropian, Chiara Sonnino, Benjamin Wallace Van Tassell, Luigi Marzio Biasucci, Antonio Abbate · 2015 · European Heart Journal Acute Cardiovascular Care
12. Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study
    Erik S.G. Stroes, John R. Guyton, Norman E. Lepor, Fernando Civeira, Daniel Gaudet, Gerald Francis Watts, Marie T. Baccara‐Dinet, Guillaume Lecorps, Garen Z. Manvelian, Michel Farnier et al. · 2016 · Journal of the American Heart Association
13. Induction of the Cytoprotective Enzyme Heme Oxygenase-1 by Statins Is Enhanced in Vascular Endothelium Exposed to Laminar Shear Stress and Impaired by Disturbed Flow
    Faisal Ali, Mustafa Zakkar, Kersti Karu, Elaine A. Lidington, Shahir Hamdulay, Joseph J. Boyle, Mire Zloh, Andrea Bauer, Dorian O. Haskard, Paul Charles Evans et al. · 2009 · Journal of Biological Chemistry
14. Lipids, atherosclerosis and CVD risk: Is CRP an innocent bystander?
    Børge Grønne Nordestgaard, Jeppe Zacho · 2009 · Nutrition Metabolism and Cardiovascular Diseases
15. Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4
    Anna Planagumà, M A Pfeffer, G Rubin, Roxanne H. Croze, Mohib Uddin, Charles Nicholas Serhan, Bruce D. Levy · 2010 · Mucosal Immunology
16. C-reactive protein: Risk factor, biomarker and/or therapeutic target?
    Jacques J. Genest · 2010 · Canadian Journal of Cardiology
17. The autoimmune concept of atherosclerosis
    Cecilia Grundtman, Georg Wick · 2011 · Current Opinion in Lipidology
18. Are Markers of Inflammation More Strongly Associated with Risk for Fatal Than for Nonfatal Vascular Events?
    Naveed A. Sattar, Heather M. Murray, Paul I. Welsh, Gerard J. Blauw, Brendan Martin Buckley, Stuart M. Cobbe, Anton J.M. de Craen, Gordon D O Lowe, J. Wouter Jukema, Peter W. Macfarlane et al. · 2009 · PLoS Medicine
19. Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration
    Peter Willeit, Simon G. Thompson, Stefan Agewall, Göran M.L. Bergström, Horst Bickel, Alberico Luigi Catapano, Kuo‐Liong Chien, Eric de Groot, Jean Philippe Empana, Thorleif Etgen et al. · 2014 · European Journal of Preventive Cardiology
20. Prevention of Cardiovascular Disease in Women
    Anum Saeed, June Kampangkaew, Vijay Nambi · 2017 · Methodist DeBakey Cardiovascular Journal
21. The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
    Nicholas Marston, Yared Gurmu, Giorgio E. M. Melloni, Marc P. Bonaca, Bariş Gencer, Peter S. Sever, Terje Rolf Pedersen, ANTHONY C. KEECH, Carolina Roselli, Steven A. Lubitz et al. · 2020 · Circulation
22. Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA PREVENT Cardiovascular Risk Equations
    James A. Diao, Ivy Shi, Venkatesh Locharla Murthy, Thomas A. Buckley, Chirag J. Patel, Emma Pierson, Robert W. Yeh, Dhruv S. Kazi, Rishi K. Wadhera, Arjun Kumar Manrai · 2024 · JAMA
23. The Clinical Utility of High-Sensitivity C-Reactive Protein in Cardiovascular Disease and the Potential Implication of JUPITER on Current Practice Guidelines
    Samia Mora, Kiran Musunuru, Roger Scott Blumenthal · 2008 · Clinical Chemistry
24. Primary prevention of stroke: blood pressure, lipids, and heart failure
    Matthias Endres, Peter Ulrich Heuschmann, Ulrich Laufs, A. M. Hakim · 2011 · European Heart Journal
25. Highlights of 10 years of immunology in Nature Reviews Immunology
    Ruslan M. Medzhitov, Ethan M. Shevach, Giorgio Trinchieri, Andrew L. Mellor, David H. Munn, Siamon Gordon, Peter Libby, Göran K. Hansson, Ken Shortman, Chen Dong et al. · 2011 · Nature reviews. Immunology
26. Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis
    Carlo Custodero, Alessandro Ciavarella, Francesco Panza, Davide Gnocchi, Gennaro Mariano Lenato, Juhan Lee, Antonio Mazzocca, Carlo Sabbà, Vincenzo Solfrizzi · 2022 · GeroScience
27. Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia
    Michael S. Kostapanos, Haralampos J. Milionis, Moses Elisaf · 2010 · American Journal of Cardiovascular Drugs
28. Differential association between the progression of coronary artery calcium score and coronary plaque volume progression according to statins: the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging (PARADIGM) study
    Sang‐Eun Lee, Ji Min Sung, Daniele Andreini, Matthew Jay Budoff, Filippo Cademartiri, Kavitha M. Chinnaiyan, Jung Hyun Choi, Eun Ju Chun, Edoardo Conte, Ilan Gottlieb et al. · 2019 · European Heart Journal - Cardiovascular Imaging
29. Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment
    Miles Trupp, Hongjie Zhu, William R. Wikoff, Rebecca Baillie, Zhao‐Bang Zeng, Peter D. Karp, Oliver Fiehn, Ronald M. Krauss, Rima F Kaddurah-Daouk · 2012 · PLoS ONE
30. Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy
    Jacqueline Suk Danik, Daniel I. Chasman, Jean G. MacFadyen, Fredrik Nyberg, Bryan J. Barratt, Paul M. Ridker · 2013 · American Heart Journal
31. Meta-Analysis of Randomized Controlled Trials of Statins Versus Placebo in Patients With Heart Failure
    Michael Joseph Lipinski, Clay A. Cauthen, Giuseppe Biondi‐Zoccai, Antonio Abbate, Bojan Vrtovec, Bobby V. Khan, George Wayne Vetrovec · 2009 · The American Journal of Cardiology
32. Statins and the Risk of Diabetes: Evidence From a Large Population-Based Cohort Study
    Giovanni Corrao, Buthaina Ibrahim, Federica Nicotra, Davide Soranna, Luca Giuseppe Merlino, Alberico Luigi Catapano, Elena Tragni, Manuela Casula, Guido M. Grassi, Giuseppe Mancia · 2014 · Diabetes Care
33. Association Between Obesity, High-Sensitivity C-Reactive Protein ≥2 mg/L, and Subclinical Atherosclerosis
    Michael Joseph Blaha, Juan J. Rivera, Matthew Jay Budoff, Ron Blankstein, Arthur A. Agatston, Daniel H. O’Leary, Mary Cushman, Susan C. Gilchrist, Michael H. Criqui, Moysés Szklo et al. · 2011 · Arteriosclerosis Thrombosis and Vascular Biology
34. Coffee or tea: Anti-inflammatory properties in the context of atherosclerotic cardiovascular disease prevention
    Stanisław Surma, Amirhossein Sahebkar, Maciej Banach · 2022 · Pharmacological Research
35. Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes
    on behalf of the FinnDiane Study Group, Troels Krarup Hansen, Carol M. Forsblom, Markku Saraheimo, Lena M. Thorn, Johan Wadén, Pernille Høyem, Jakob Appel Østergaard, Allan Flyvbjerg, Per‐Henrik Groop · 2010 · Diabetologia
36. Does Inflammation Determine Whether Obesity Is Metabolically Healthy or Unhealthy? The Aging Perspective
    Iftikhar Alam, Tze Pin Ng, Anis Larbi · 2012 · Mediators of Inflammation
37. The use of statins in people at risk of developing diabetes mellitus: Evidence and guidance for clinical practice
    Naveed A. Sattar, Henry N. Ginsberg, Kausik Kumar Ray, M. John Chapman, Marcello Arca, Maurizio Rocco Averna, D. J. Betteridge, Deepak Bhatnagar, Elena Bilianou, Rafael Carmena et al. · 2014 · Atherosclerosis Supplements
38. Plasma Myeloperoxidase Predicts Incident Cardiovascular Risks in Stable Patients Undergoing Medical Management for Coronary Artery Disease
    W.H. Wilson Tang, Yuping Wu, Stephen James Nicholls, Stanley L. Hazen · 2010 · Clinical Chemistry
39. Human C-Reactive Protein Does Not Promote Atherosclerosis in Transgenic Rabbits
    Tomonari Koike, Shuji Kitajima, Ying Yu, Kazutoshi Nishijima, Jifeng Zhang, Yukio Ozaki, Masatoshi Morimoto, Teruo Watanabe, Sucharit Bhakdi, Yujiro Asada et al. · 2009 · Circulation
40. Lipoprotein(a) and Cardiovascular Risk Prediction Among Women
    Nancy R. Cook, Samia Mora, Paul M. Ridker · 2018 · Journal of the American College of Cardiology
41. JCS 2018 Guideline on Diagnosis of Chronic Coronary Heart Diseases
    Masakazu Yamagishi, Nagara Tamaki, Takashi Akasaka, Takanori Ikeda, Kenji Ueshima, Shiro Uemura, Yutaka Otsuji, Yasuki Kihara, Kazuo Kimura, Takeshi Kimura et al. · 2021 · Circulation Journal
42. The negative effects of hydrogenated trans fats and what to do about them
    Fred A. Kummerow · 2009 · Atherosclerosis
43. Preliminary Findings Regarding Proinflammatory Markers and Brain-Derived Neurotrophic Factor Among Adolescents with Bipolar Spectrum Disorders
    Benjamin I. Goldstein, Katelyn A. Collinger, Francis E. Lotrich, Anna L. Marsland, MaryKay Gill, David Axelson, Boris B. Birmaher · 2011 · Journal of Child and Adolescent Psychopharmacology
44. Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease
    Tomoya Yamashita, Naoto Sasaki, Kazuyuki Kasahara, Ken‐ichi Hirata · 2015 · Journal of Cardiology
45. NASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages
    Veerle Bieghs, Patrick C.N. Rensen, Marten H. Hofker, Ronit Shiri‐Sverdlov · 2011 · Atherosclerosis
46. Rosuvastatin: Beyond the cholesterol-lowering effect
    Francesca Cortese, Michele Gesualdo, Anna Maria Cortese, Santa Carbonara, Fiorella Devito, Annapaola Zito, Gabriella Ricci, Pietro Scicchitano, Marco Matteo Ciccone · 2016 · Pharmacological Research
47. Statins inhibit protein lipidation and induce the unfolded protein response in the non-sterol producing nematode Caenorhabditis elegans
    Catarina Mörck, Louise C. B. Olsen, Caroline Kurth, Annelie Persson, Nadia Jin Storm, Emma Svensson, John‐Olov Jansson, Marika Hellqvist, Annika M. K. Enejder, Nils Joakim Færgeman et al. · 2009 · Proceedings of the National Academy of Sciences
48. Biomarkers in the Critically Ill Patient: C-reactive Protein
    Jean‐Louis Vincent, Katia Donadello, Xavier Schmit · 2011 · Critical Care Clinics
49. Association Between Plasma Monocyte Chemoattractant Protein-1 Concentration and Cardiovascular Disease Mortality in Middle-Aged Diabetic and Nondiabetic Individuals
    Lorenzo Piemonti, Giliola Calori, Guido Lattuada, Alessia Mercalli, Francesca Ragogna, Maria Paola Garancini, Giacomo Ruotolo, Livio Luzi, Gianluca Perseghin · 2009 · Diabetes Care
50. Associations between statins and COPD: a systematic review
    Claudia Caroline Dobler, KEITH K. H. WONG, Guy Barrington Marks · 2009 · BMC Pulmonary Medicine
51. Gender-Related Factors in Medication Adherence for Metabolic and Cardiovascular Health
    Vittorio Venditti, Enrico Bleve, Susanna Morano, Tiziana Filardi · 2023 · Metabolites
52. Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy: A Meta-analysis
    Peter Paul Toth · 2012 · Yearbook of Medicine
53. The Evolving Role of HDL in the Treatment of High-Risk Patients with Cardiovascular Disease
    H. Bryan Brewer · 2011 · The Journal of Clinical Endocrinology & Metabolism
54. Statins and Risk of New-Onset Diabetes Mellitus
    Ravi V. Shah, Allison B. Goldfine · 2012 · Circulation
55. Circulating Progenitor Cell Count for Cardiovascular Risk Stratification: A Pooled Analysis
    Gian Paolo Fadini, Shoichi Maruyama, Takenori Ozaki, Akihiko Taguchi, James B. Meigs, Stefanie Dimmeler, Andreas Michael Zeiher, Saula de Kreutzenberg, Angelo Avogaro, Georg Nickenig et al. · 2010 · PLoS ONE
56. Colchicine’s Role in Cardiovascular Disease Management
    Leo Francis Buckley, Peter Libby · 2024 · Arteriosclerosis Thrombosis and Vascular Biology
57. Effect of statin therapy on mortality from infection and sepsis: a meta-analysis of randomized and observational studies
    You-Dong Wan, Tong-Wen Sun, Quan-Cheng Kan, Fang-Xia Guan, Shu-Guang Zhang · 2014 · Critical Care
58. Major Contribution of the P2Y 1 Receptor in Purinergic Regulation of TNFα-Induced Vascular Inflammation
    Murielle Zerr, Béatrice Hechler, Monique Freund, Stéphanie Magnenat, Isabelle Lanois, Jean‐Pierre Cazenave, Catherine Léon, Christian Gachet · 2011 · Circulation
59. Progression of asymptomatic carotid stenosis despite optimal medical therapy
    Mark Frederick Conrad, Valy Baloum, Shankha Mukhopadhyay, Ashu Garg, Virendra I. Patel, Richard P. Cambria · 2013 · Journal of Vascular Surgery
60. Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) Registry
    Navar, Ann Marie, Wang, Tracy Y., Li, Shuang, Robinson, Jennifer G., Goldberg, Anne C., Virani, Salim, Roger, Veronique L., Wilson, Peter W.F., Elassal, Joseph, Lee, L. Veronica et al. · 2017 · American Heart Journal
61. The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction
    Jonathan D. Newman, Anish K. Vani, José O. Alemán, HOWARD S. WEINTRAUB, Jeffrey S. Berger, Arthur Z. Schwartzbard · 2018 · Journal of the American College of Cardiology
62. Osteopontin in Cardiovascular Diseases
    Kohsuke Shirakawa, Motoaki Sano · 2021 · Biomolecules
63. Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
    Nick S. Nurmohamed, Marc Ditmarsch, John J.P. Kastelein · 2021 · Cardiovascular Research
64. Perspectives of the non-statin hypolipidemic agents
    Damjana Rozman, Katalin Monostory · 2010 · Pharmacology & Therapeutics
65. Biomarkers of premature atherosclerosis
    Anna–Maria Kampoli, Dimitris Tousoulis, Charalambos A. Antoniades, Gerasimos Siasos, Christodoulos Stefanadis · 2009 · Trends in Molecular Medicine
66. Proof of Concept, Randomized, Placebo-Controlled Study of the Effect of Simvastatin on the Course of Age-Related Macular Degeneration
    Robyn H. Guymer, Paul Nigel Baird, Mary Varsamidis, Lucy Busija, Peter N Dimitrov, Khin Zaw Aung, Galina A. Makeyeva, Andrea Jane Richardson, Lyndell L. Lim, Liubov D. Robman · 2013 · PLoS ONE
67. Inflammation and atherosclerosis: Cardiovascular evaluation in patients with autoimmune diseases
    Ricardo Orlando Escarcega, Michael Joseph Lipinski, Mario García‐Carrasco, Claudia Mendoza Pinto, José Luis Gálvez-Romero, Ricard Cervera · 2018 · Autoimmunity Reviews
68. The Use of High Sensitivity C-Reactive Protein in Cardiovascular Disease Detection
    Ana Rita Castro, Sara Oliveira Silva, Sandra Clara Soares · 2018 · Journal of Pharmacy & Pharmaceutical Sciences
69. A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia
    Maged M. Costantine, Holly A. West, Katherine L. Wisner, Steve N. Caritis, Shannon M. Clark, Raman Venkataramanan, Catherine Susan Stika, Erik Rytting, Xiaoming Wang, Mahmoud S. Ahmed et al. · 2021 · American Journal of Obstetrics and Gynecology
70. Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association
    Larry B. Goldstein, Peter Paul Toth, Jennifer L. Dearborn, Robert Patrick Giugliano, Benjamin J. Hirsh, Jessica M. Peña, Magdy H. Selim, Daniel Woo · 2023 · Arteriosclerosis Thrombosis and Vascular Biology
71. Inflammatory Trajectory of Type 2 Diabetes: Novel Opportunities for Early and Late Treatment
    Valeria Pellegrini, Rosalba La Grotta, Francesca Carreras, Angelica Giuliani, Jacopo Sabbatinelli, Fabiola Olivieri, Cesare Berra, Antonio Ceriello, Francesco Prattichizzo · 2024 · Cells
72. Higher Neutrophil/Lymphocyte Ratio Is Related to Lower Ejection Fraction and Higher Long-term All-Cause Mortality in ST-Elevation Myocardial Infarction Patients
    Yaron Arbel, Yacov Shacham, Tomer Ziv‐Baran, Michal Laufer Perl, Ariel Finkelstein, Amir Halkin, Miri Revivo, Assi Milwidsky, Shlomo A. Berliner, Itzhak Herz et al. · 2014 · Canadian Journal of Cardiology
73. Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicine
    Ying Gu, Clay Walker, MARIA EMANUEL RYAN, Jeffrey B. Payne, Lorne M. Golub · 2012 · Journal of Oral Microbiology
74. Statin induced diabetes and its clinical implications
    Umme Aiman, Ahmad Najmi, Rahat Ali Khan · 2014 · Journal of Pharmacology and Pharmacotherapeutics
75. Statins and its hepatic effects: Newer data, implications, and changing recommendations
    Jimmy José · 2015 · Journal of Pharmacy And Bioallied Sciences
76. Reduction of low-density lipoprotein cholesterol by monoclonal antibody inhibition of PCSK9
    Stein, Evan A., Raal, Frederick · 2014 · Annual Review of Medicine
77. Antihypertensive drugs and glucose metabolism
    Christos V. Rizos · 2014 · World Journal of Cardiology
78. Statins: Then and Now
    Peter Paul Toth, Maciej Banach · 2019 · Methodist DeBakey Cardiovascular Journal
79. High Sensitivity C-reactive Protein (hsCRP) and its Implications in Cardiovascular Outcomes
    Andrea Denegri, Giuseppe Boriani · 2020 · Current Pharmaceutical Design
80. Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease
    William Nseir, Adel Shalata, Alon T Marmor, Nimer Assy · 2011 · Digestive Diseases and Sciences
81. LDL Cholesterol: The Lower the Better
    Seth Shay Martin, Roger Scott Blumenthal, Michael J. Miller · 2012 · Medical Clinics of North America
82. Carotid Artery Atherosclerosis: Effect of Intensive Lipid Therapy on the Vasa Vasorum—Evaluation by Using Dynamic Contrast-enhanced MR Imaging
    Li Dong, W. Kerwin, Huijun Chen, Baocheng Chu, Hunter R. Underhill, Moni Blazej Neradilek, Thomas S. Hatsukami, Chun Yuan, Xue Qiao Zhao · 2011 · Radiology
83. The CANTOS Trial
    Richard A. Baylis, Delphine A Gomez, Ziad Mallat, Gerard Pasterkamp, Gary K. Owens · 2017 · Arteriosclerosis Thrombosis and Vascular Biology
84. All Men with Vasculogenic Erectile Dysfunction Require a Cardiovascular Workup
    Martin M. Miner, Ajay X. Nehra, Graham Jackson, Shalender Bhasin, Kevin L. Billups, Arthur L. “Bud” Burnett, Jacques Buvat, Culley C. Carson, Glenn R. Cunningham, Peter Ganz et al. · 2013 · The American Journal of Medicine
85. Carotid Artery Stenosis: Medical Therapy, Surgery, and Stenting
    Sushrut Dharmakidari, Pratik D. Bhattacharya, Seemant Chaturvedi · 2017 · Current Neurology and Neuroscience Reports
86. Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Trøndelag Health [HUNT] Study)
    Fjola D. Sigurdardottir, Magnus Nakrem Lyngbakken, Oddgeir L. Holmen, Håvard Dalen, Kristian Hveem, Helge Rørvik Røsjø, Torbjørn Omland · 2018 · The American Journal of Cardiology
87. Inflammation as A Precursor of Atherothrombosis, Diabetes and Early Vascular Aging
    Elena Barbu, Mihaela-Roxana Popescu, Andreea-Catarina Popescu, Serban Mihai Balanescu · 2022 · International Journal of Molecular Sciences
88. C-reactive protein, immunothrombosis and venous thromboembolism
    Caroline H. K. Dix, Johannes Zeller, Hannah Stevens, Steffen U. Eisenhardt, Karen S. Cheung Tung Shing, Tracy L. Nero, Craig J. Morton, Michael W. Parker, Karlheinz Peter, James D. McFadyen · 2022 · Frontiers in Immunology
89. Statins, inflammation and kidney disease
    Vera Krane, Christoph Wanner · 2011 · Nature Reviews Nephrology
90. Clinical implications of inflammation for cardiovascular primary prevention
    Peter Libby, Filippo Crea · 2010 · European Heart Journal
91. Monomeric C-reactive protein is prothrombotic and dissociates from circulating pentameric C-reactive protein on adhered activated platelets under flow
    Blanca Molins, Esther Peña, Raquel de la Torre, Lina Badimón · 2011 · Cardiovascular Research
92. Oxidized LDL Receptor LOX-1 Binds to C-Reactive Protein and Mediates Its Vascular Effects
    Yoshiko Fujita, Akemi Kakino, Norihisa Nishimichi, Saburo Yamaguchi, Yuko Sato, Sachiko Machida, Luciano Cominacini, Yves Delneste, Haruo Matsuda, Tatsuya Sawamura · 2008 · Clinical Chemistry
93. Pathophysiology and management of cardiovascular disease in patients with HIV
    Eric Nou, Janet Lo, Colleen M. Hadigan, Steven Kyle Grinspoon · 2016 · The Lancet Diabetes & Endocrinology
94. Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia
    Luca Puccetti, Francesca Santilli, Anna Laura Pasqui, Stefano Lattanzio, Rossella Liani, Federica Ciani, Elisabetta Ferrante, Giovanni Ciabattoni, Francesca Scarpini, Anna Rita Ghezzi et al. · 2010 · Atherosclerosis
95. Critical appraisal of inflammatory markers in cardiovascular risk stratification
    Magdalena Krintus, Marek Koziński, Jacek Kubica, Grażyna Sypniewska · 2014 · Critical Reviews in Clinical Laboratory Sciences
96. Effect of Statin Treatment on Modifying Plaque Composition
    Seung‐Jung Park, Soo‐Jin Kang, Jung‐Min Ahn, Mineok Chang, Sung‐Cheol Yun, Jae‐Hyung Roh, Pil Hyung Lee, Hyun Woo Park, Sung‐Han Yoon, Duk‐Woo Park et al. · 2016 · Journal of the American College of Cardiology
97. Intracoronary Imaging, Cholesterol Efflux, and Transcriptomes After Intensive Statin Treatment
    Annapoorna Subhash Kini, Yuliya Vengrenyuk, Khader Shameer, Akiko Maehara, Purushothaman Meerarani, Takahiro Yoshimura, Mitsuaki Matsumura, Melissa B. Aquino, Nezam Haider, Kipp W. Johnson et al. · 2016 · Journal of the American College of Cardiology
98. LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins
    Wei‐Qi Wei, Xiaohui Li, QiPing Feng, Michiaki Kubo, Iftikhar J. Kullo, Peggy L. Peissig, Elizabeth W. Karlson, Gail Pairitz Jarvik, Ming Ta Michael Lee, Ning Shang et al. · 2018 · Circulation
99. Intensive Statin Treatment in Acute Ischaemic Stroke Patients with Intracranial Atherosclerosis: a High-Resolution Magnetic Resonance Imaging study (STAMINA-MRI Study)
    Jong‐Won Chung, Jihoon Cha, Mi Ji Lee, Inwu Yu, Moo‐Seok Park, Woo‐Keun Seo, Sung Tae Kim, Oh Young Bang · 2019 · Journal of Neurology Neurosurgery & Psychiatry
100. Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms
     Luca Liberale, Federico Carbone, Fabrizio Montecucco, Amirhossein Sahebkar · 2020 · The International Journal of Biochemistry & Cell Biology